Greenbrook TMS Inc. (OTCPK: GBNH.F)
Health Care · Health Care Providers & Services · CA
$—
— today · — 1Y
Greenbrook TMS Inc. (OTCPK: GBNH.F) operates in the Health Care Providers & Services industry within the Health Care sector.
Tweenvest scores Greenbrook TMS Inc. across four factors: quality 16/100, growth 90/100. Its strongest factor is growth.
GBNH.F price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- —
- Revenue (TTM)
- $76.92M
- P/E
- —
- EPS
- -1.10
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- $—
- 52-week low
- $—
- Avg volume (3M)
- —
- Shares outstanding
- —
- Employees
- 644
- Next earnings
- —
About Greenbrook TMS Inc.
Greenbrook TMS Inc., together with its subsidiaries, controls and operates a network of outpatient mental health services centers in the United States. Its centers specialize in the provision of transcranial magnetic stimulation (TMS) therapy, an FDA-cleared non-invasive therapy for the treatment of major depressive disorder and other mental health disorders, as well as related psychiatric services. As of December 31, 2021, the company operated 94 wholly owned and 55 TMS centers in the commonwealth of Virginia and the States of Maryland, Delaware, North Carolina, Missouri, Illinois, Ohio, Texas, Connecticut, Florida, South Carolina, Michigan, Alaska, Oregon, California, Iowa, and Massachusetts. Greenbrook TMS Inc. was founded in 2011 and is headquartered in Toronto, Canada.
- ISIN
- CA3937043097
- Founded
- 2011
- Listed since
- Oct 3, 2018
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Health Care Providers & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| UnitedHealth Group IncorporatedNYSE: UNH | $350.16B | $390.11 | +1.37% |
| CVS Health CorporationNYSE: CVS | $118.97B | $93.02 | -0.67% |
| McKesson CorporationNYSE: MCK | $100.14B | $858.90 | +2.40% |
| HCA Healthcare, Inc.NYSE: HCA | $92.92B | $429.19 | +5.64% |
| Elevance Health, Inc.NYSE: ELV | $86.86B | $400.54 | +1.07% |
| The Cigna GroupNYSE: CI | $73.33B | $277.51 | +1.13% |
| Cencora, Inc.NYSE: COR | $60.69B | $318.04 | +1.06% |
| Cardinal Health, Inc.NYSE: CAH | $53.38B | $229.51 | +0.46% |
Figures last refreshed Aug 18, 2026.